Previous close | 60.59 |
Open | 60.85 |
Bid | 61.09 x 200 |
Ask | 61.25 x 200 |
Day's range | 60.27 - 62.88 |
52-week range | 20.66 - 66.54 |
Volume | |
Avg. volume | 425,241 |
Market cap | 2.4B |
Beta (5Y monthly) | 1.20 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Like its patients, RxSight has 20/20 vision — at least where profitability is concerned. And RxSight stock is approaching another record.
We have narrowed our search to five Medical Instruments stocks with strong potential for 2024. These stocks are: ALC, RXST, HOLX, VCYT, MASI.
A week ago, RxSight, Inc. ( NASDAQ:RXST ) came out with a strong set of quarterly numbers that could potentially lead...